Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term refers to a complex network of pattern recognition receptors (PRRs) and downstream signaling molecules on dendritic cells (DCs) that specifically interact with allergens like ArtCaM (Artemisia vulgaris Calmodulin, also known as Art v 6). These receptors, primarily including C-type lectin receptors (CLRs) and Toll-like receptors (TLRs), detect specific structural motifs or enzymatic activities of allergens to initiate immune responses. Upon binding, these receptors trigger intracellular signaling cascades involving molecules like Syk, Raf-1, or MyD88, which ultimately lead to DC maturation and the secretion of cytokines that drive Th2 cell differentiation. This machinery is a critical checkpoint in the sensitization phase of allergic diseases, as it determines whether an inhaled or ingested protein is perceived as harmless or as a threat requiring an IgE-mediated response. While not a single therapeutic target, the components of this machinery are being investigated for their potential to be modulated in allergen-specific immunotherapy or to prevent the onset of allergic sensitization.
The machinery involves the recognition of allergen-associated molecular patterns (AAMPs) by pattern recognition receptors (PRRs) such as C-type lectin receptors (e.g., MR, DC-SIGN) and TLRs, leading to the activation of Syk or MyD88-dependent signaling pathways that polarize T-cell responses toward a Th2 phenotype.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dendritic cell surface receptors and signaling machinery engaged by ArtCaM and other allergens (DC-Allergen Receptors).